BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15229130)

  • 1. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype.
    Singhal S; Bevan S; Barrick T; Rich P; Markus HS
    Brain; 2004 Sep; 127(Pt 9):2031-8. PubMed ID: 15229130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
    Peters N; Holtmannspötter M; Opherk C; Gschwendtner A; Herzog J; Sämann P; Dichgans M
    Neurology; 2006 May; 66(10):1517-22. PubMed ID: 16717211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of hereditary cerebrovascular disease in a large family from Colombia].
    Lopera F; Arboleda J; Moreno S; Almeida N; Cuartas M; Arcos-Burgos M
    Rev Neurol; 2000 Nov 16-30; 31(10):901-7. PubMed ID: 11244680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
    Gladstone JP; Dodick DW
    Neurologist; 2005 Jan; 11(1):19-29. PubMed ID: 15631641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine.
    de Tommaso M; Difruscolo O; Sardaro M; Losito L; Serpino C; Pietrapertosa A; Santeramo MT; Dicuonzo F; Carella A; Lamberti P; Livrea P
    Headache; 2007 Feb; 47(2):253-65. PubMed ID: 17300365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
    Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL.
    Vahedi K; Chabriat H; Levy C; Joutel A; Tournier-Lasserve E; Bousser MG
    Arch Neurol; 2004 Aug; 61(8):1237-40. PubMed ID: 15313840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dominant autosomal cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A review].
    Navarro E; Díaz F; Muñoz L; Giménez-Roldán S
    Neurologia; 2002 Oct; 17(8):410-7. PubMed ID: 12396971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
    Flemming KD; Nguyen TT; Abu-Lebdeh HS; Parisi JE; Wiebers DO; Sicks JD; O'Fallon WM; Petty GW
    Mayo Clin Proc; 2001 Dec; 76(12):1213-8. PubMed ID: 11761502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and lekoencephalopathy) with Notch 3 (Arg169Cys) mutation and typical granular osmiophilic materials in peripheral small arteries].
    Kotani N; Hara H; Fujimura H; Miyashita T; Miyaguchi K; Tabira T
    Rinsho Shinkeigaku; 2004; 44(4-5):274-9. PubMed ID: 15287509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Japanese CADASIL case with limited dementia who had the Notch 3 R141C mutation].
    Ishibashi K; Murata T; Miki Y; Hara M; Mori H
    No To Shinkei; 2005 May; 57(5):415-8. PubMed ID: 15981641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals.
    Adib-Samii P; Brice G; Martin RJ; Markus HS
    Stroke; 2010 Apr; 41(4):630-4. PubMed ID: 20167921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phenotypic spectrum of CADASIL: clinical findings in 102 cases.
    Dichgans M; Mayer M; Uttner I; Brüning R; Müller-Höcker J; Rungger G; Ebke M; Klockgether T; Gasser T
    Ann Neurol; 1998 Nov; 44(5):731-9. PubMed ID: 9818928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cognitive profiles of CADASIL and sporadic small vessel disease.
    Charlton RA; Morris RG; Nitkunan A; Markus HS
    Neurology; 2006 May; 66(10):1523-6. PubMed ID: 16717212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the Notch 3 gene in a Thai cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy family.
    Suwanwela N; Srikiatkhachorn A; Tangwongchai S; Phanthumchina K; Suwanwela N
    J Med Assoc Thai; 2003 Feb; 86(2):178-82. PubMed ID: 12678157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of apolipoprotein E and cognitive function in old age.
    Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
    Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of apolipoprotein E and risk of stroke in old age.
    van Vliet P; Mooijaart SP; de Craen AJ; Rensen PC; van Heemst D; Westendorp RG
    Ann N Y Acad Sci; 2007 Apr; 1100():140-7. PubMed ID: 17460172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CADASIL: clinical analysis of CADASIL and CADASIL-like disorders in Japan].
    Uchino M; Uyama E; Maeda Y; Hirano T; Suenaga A; Yamada H; Hashimoto Y; Kotorii S; Takahashi K; Tabira T
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1247-50. PubMed ID: 11464469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
    Herak DC; Antolic MR; Krleza JL; Pavic M; Dodig S; Duranovic V; Brkic AB; Zadro R
    Pediatrics; 2009 Apr; 123(4):e653-60. PubMed ID: 19336355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hereditary cerebral arteriopathy].
    Gustavsen WR; Eiklid K
    Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3045-6. PubMed ID: 14618173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.